A 72-year-old female with end-stage renal disease due to chronic glomerulonephritis had been treated with conventional haemodialysis for 6 years. She was referred three months ago for management of blisters and cutaneous fragility on the dorsa of both hands ([Figure 1](#fig1){ref-type="fig"}a and b). The patient denied extensive sun exposure, sun beds, or use of medications other than calcium carbonate, vitamin B complex, folic acid or erythropoietin. Haemodialysis was performed tri-weekly, 4 h per session, via an arteriovenous fistula over the left forearm, using a cellulose acetate dialyser (FB170, Nipro, Japan). The blood and dialysate flow rates were 200 and 500 cm^3^/min, and delivered Kt/V (Daugirdas) and urea reduction rates were 1.89 and 0.79, respectively. Blood tests were negative for anti-nuclear, anti-intercellular substance and anti-basement membrane zone antibodies. Urine was also negative for porphyrin and coproporphyrin (spectrophotometry). Skin biopsy ([Figure 1](#fig1){ref-type="fig"}c) found a subepidermal vesicle with tombstone-like protruding papillary dermis, whereas immunofluorescence analysis revealed smooth linear vascular staining by IgG ([Figure 1](#fig1){ref-type="fig"}d) and IgA. Pseudoporphyria was diagnosed. The blistering lesions gradually improved after initiation of high-flux haemodialysis with a polysulphone dialyser (F80, Fresenius, Germany). At the time of follow-up, the blood and dialysate flow rates were 280 and 500 cm^3^/min, and delivered Kt/V (Daugirdas) and urea reduction rates were 2.40 and 0.83, respectively.

![Pseudoporphyria in a haemodialysis patient. (**a**, **b**) Blisters (white asterisk) and cutaneous fragility found on the dorsa of both hands. (**c**) Haematoxylin and eosin staining found a subepidermal vesicle with tombstone-like protruding papillary dermis and focal extravasation of red blood cells in papillary dermis. No significant inflammatory cells were seen (white asterisk: epidermis, black asterisk: vesicle, magnification × 400). (**d**) Direct immunofluorescence analysis revealed smooth linear vascular staining by IgG (white asterisk, magnification × 400).](sfq150fig1){#fig1}

Pseudoporphyria is an uncommon blistering disorder with clinical and histological similarities to porphyria cutanea tarda, but lacks urine and serum porphyrin elevations \[[@ref1]\]. Pseudoporphyria has been linked with numerous aetiologies including renal failure, ultraviolet A radiation and photosensitizing medications (naproxen, furosemide, nalidixic acid, bumetanide, tetracyclines, amiodarone, etc.) \[[@ref1]\]. It is possible that when multiple contributing factors are present in haemodialysis patients, including commonly used photosensitizing medications, the risk of pseudoporphyria may be further enhanced \[[@ref2]\]. The mechanism for induction of disease is not understood. Discontinuation of the suspected photosensitizing medication and strict ultraviolet A protection are the mainstay of treatments. Successful treatment of pseudoporphyria following *N*-acetylcysteine and high-flux haemodialysis has been reported previously \[[@ref3]\].
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